Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 12/20 | 0.40 |
| ▸ | PARP2 | Q9UGN5 | 8/20 | 0.40 |
| ▸ | PARP6 | Q2NL67 | 5/20 | 0.40 |
| ▸ | PARP3 | Q9Y6F1 | 5/20 | 0.40 |
| ▸ | RBP4 | P02753 | 1/20 | 0.34 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.33 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 2/20 | 0.32 |
| ▸ | SCD | O00767 | 1/20 | 0.32 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.32 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30428081 | 0.86 | PARP1 (0.44) | PARP1PARP2PARP6PARP3RBP4 | |
| SCHEMBL30428451 | 0.85 | PARP1 (0.43) | PARP1PARP2PARP6PARP3RBP4 | |
| SCHEMBL29085166 | 0.83 | SCN9A (0.37) | PARP1CNR2 | |
| SCHEMBL29026151 | 0.76 | PARP1 (0.42) | PARP1PARP2PARP6PARP3RBP4 | |
| SCHEMBL29026157 | 0.76 | PARP1 (0.42) | PARP1PARP2PARP6PARP3RBP4 | |
| SCHEMBL25413471 | 0.74 | PARP1 (0.48) | PARP1PARP2PARP6PARP3BAZ2B | |
| SCHEMBL30212537 | 0.73 | BACE1 (0.52) | PARP1PARP2PARP6PARP3 | |
| SCHEMBL22912731 | 0.73 | BACE1 (0.52) | PARP1PARP2PARP6PARP3 | |
| SCHEMBL4524209 | 0.72 | HTR3E (0.47) | PARP1SLC6A7 | |
| SCHEMBL31474240 | 0.72 | PARP1 (0.43) | PARP1PARP2PARP6PARP3BAZ2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116348115-A | Combination of antibody-drug conjugate and PARP1 selective inhibitor | 阿斯利康(英国)有限公司 | 2023-06-27 | — | — | CN | disclosed |